The use of a halogenated phthalein dye for the investigation of hepatic function was first proposed by Rowntree, Hurwitz and Bloomfield (1) in 1913. Their technique required the measurement of the fecal excretion of phenoltetrachlorphthalein following its parenteral administration. However, it was subsequently shown by Rosenthal and White (2) that intravenously administered phenoltetrabromophthalein disulfonate (BSP) is removed from the blood almost exclusively by the liver and that the function of the liver may therefore be evaluated by measuring the rate of disappearance of this dye from the plasma.
The use of a halogenated phthalein dye for the investigation of hepatic function was first proposed by Rowntree, Hurwitz and Bloomfield (1) in 1913. Their technique required the measurement of the fecal excretion of phenoltetrachlorphthalein following its parenteral administration. However, it was subsequently shown by Rosenthal and White (2) that intravenously administered phenoltetrabromophthalein disulfonate (BSP) is removed from the blood almost exclusively by the liver and that the function of the liver may therefore be evaluated by measuring the rate of disappearance of this dye from the plasma.
Various lines of evidence support the view that the removal of BSP (and presumably many other substances) from the plasma involves two processes: 1) storage of the material in the liver and 2) biliary excretion. Following the intravenous administration of BSP to dogs it was first shown by Wirts and Cantarow (3) that the output of BSP in the bile continues for over three hours after its virtual disappearance from the plasma, indicating that this material is first taken up by the liver and then gradually excreted. This observation was confirmed by Brauer and Pessotti (4) , also in dogs. The existence of a similar hepatic BSP storage mechanism in man is evident from the studies of Mendeloff, Kramer, Ingelfinger and Bradley (5) in which a retardation of the BSP disappearance rate from plasma was noted when successive identical intravenous dosts were administered 30 minutes apart. These authors pos-* This investigation was supported by a grant from the Department of the Army (Contract DA-49-007- tulated that "saturation" of the hepatic storage compartment occurs after a single injection of dye so that the rate of uptake of subsequent doses is limited by the biliary excretion mechanism. Fluoresence microscopy of living frog and rat livers by the technique of Grafflin and Bagley (6) has provided direct visualization of the storage phenomenon. Following intravenous injection both fluorescein and thioflavine-S accumulate in high concentration in hepatic parenchymal cells as well as in the bile canaliculi. Finally, the same process has been demonstrated after injection of I31-labeled rose bengal by Taplin, Meredith and Kade (7) using an external counter over the liver. There is a rapid accumulation of isotope in the liver followed by a gradual disappearance as the dye is excreted. The latter phase can be blocked by acute common bile duct ligation in rabbits but the "storage" uptake is still apparent.
The rate of uptake of BSP from the plasma into hepatic storage may be very rapid immediately after an intravenous injection. In man, for example, the BSP concentration in plasma falls at the rate of 10 to 15 per cent per minute following a single injection (8) so that the initial rate of removal of a 300 mg dose must be of the order of 40 mg per minute. However, the liver is incapable of removing BSP this rapidly for an extended period of time. Constant BSP infusions at rates much over 3 mg per m2 per minute in man (9) or 1.4 mg per 10 kg per minute in the dog (10) result in a continuously rising plasma concentration. Mason , Hawley and Smith ( 11 ) reported a higher figure of 4.4 mg per 10 kg per minute for dogs but arrived at the same general conclusion. These observations have led to the hypothesis that the biliary excretion of BSP is a rate-limited process and that the rate of uptake of BSP from plasma is ultimately limited by the maximal rate of excretion.
This mechanism was explored in more detail by Combes, Wheeler, Childs and Bradley (10) using 1181-labeled rose bengal to measure hepatic blood flow so that actual rates of hepatic BSP removal could be calculated from the splanchnic arteriovenous concentration difference. It was found that the removal rate of BSP reaches a limiting "maximum" during a BSP infusion which is sufficiently rapid to produce a continuously rising plasma concentration. This observation was interpreted as further evidence for the existence of a limited excretory transport mechanism, and the maximal rate of transport was designated "Tm." However, when a large "priming" dose of BSP was administered at the time that constant infusion was started, hepatic removal rates much higher than the apparent excretory "Tm" were observed transiently, suggesting rapid initial uptake of BSP into a "storage" compartment. It was postulated that the liver is capable of very rapid uptake of BSP from the plasma when the dye is entering the storage compartment but that the uptake approaches the excretory "Tm" once the storage compartment is "saturated."
The high plasma concentrations of BSP required for more detailed exploration of the storage mechanism interfered markedly with the removal of rose bengal making it impossible to obtain accurate measurements of hepatic blood flow. In the studies reported here a mechanical device (rotameter) was therefore employed for the measurement of flow in order to determine hepatic BSP uptake accurately over a wide range of plasma levels in the dog. The results have proved consistent with' the view that biliary excretion of BSP involves a rate-limited process but that accumulation (or storage) of BSP in hepatic parenchymal cells is determined by plasma concentration.
METHODS
In 14 mongrel dogs (14 to 26 kg) anesthetized with pentobarbital (30 mg per kg) hepatic venous outflow was measured using the rotameter and optical recording system described by Shipley and Wilson (12) . In the first 6 dogs hepatic venous blood was collected from the inferior vena cava below the liver and returned through a chest wound to the thoracic inferior vena cava (Figure 1 Hepatic venous blood was collected through cannula (A), delivered to rotameter (B) and returned to heart by way of cannula in thoracic inferior vena cava (C). Blood from structures below (A) was collected through femoral vein cannulae (D) and returned to heart via jugular cannulae (E). Mixed hepatic venous blood samples were obtained at F. return tubing was regulated to maintain constant body temperature (measured by an esophageal thermistor). A cardiac catheter equipped with a balloon was inserted through the other external jugular vein and maneuvered into the thoracic inferior vena cava. Its position was determined by palpation through the intact diaphragm. Inflation of this balloon directed the entire hepatic venous outflow through the rotameter. Hepatic venous congestion did not occur, because the resistance of the tubing and rotameter to hepatic venous outflow was balanced by the siphoning effect of the blood delivered to the dependent reservoir.
In all studies heparin was used as the anticoagulant (10 mg per kg initially and 5 mg per kg every hour, intravenously). The external circuits were filled beforehand with 6 per cent dextran in saline to prevent sudden initial reduction in blood volume. The rotameter was calibrated frequently with dog blood at body temperature and in each of the last 8 studies this calibration was carried out immediately after completing the experiment. Sulfobromophthalein sodium (BSP) solutions were administered intravenously using a Bowman pump.
BSP concentration in arterial and hepatic venous plasma was measured in a Beckman DU spectrophotometer at 580 m,u after dilution of 1 ml of plasma with 10 ml of normal saline and addition of 0. Measurements of flow and collection of blood specimens were carried out synchronously at intervals of 3 to 10 minutes and the values of F, A and V, obtained at the beginning and end of each interval, were averaged and substituted into the above equation to calculate Ri for the interval. The difference between the arterial concentrations at the beginning and end of each period was divided by the time interval to obtain At During sudden changes in concentration following large injections of BSP (see Figures 4 and 5) continuous blood samples were drawn at a constant rate for 2 successive periods of 2 minutes' duration in order to obtain representative average values for A and V.
RESULTS
The first six studies demonstrate the effect of sudden alterations in arterial BSP concentration on the hepatic BSP removal rate. In the study illustrated in Figure 3 (Dog Hu) a constant BSP infusion of 3.8 mg per minute was administered. As anticipated from earlier work (10) terval. During the resulting decrement in arterial concentration the hepatic removal rate decreased to as low as 0.7 mg per minute but returned again to 2 mg per minute after resumption of the infusion. This reduction in BSP removal rate occurred even though the absolute arterial BSP concentration was always higher than during the control period.
The other four studies in this series ( Figure 5 ) confirm the observations described above. Sudden increments in plasma level produced either by instantaneous intravenous doses of BSP ( Figure  5A , B, C) or temporary acceleration of infusion rate ( Figure 5D ) invariably resulted in significant transient increase in hepatic removal rate. Moreover, in Dog Sa ( Figure 5D ) the responses elicited by each of two successive concentration increments were identical. On the other hand, concentration decrements ( Figure 5A , B, C) resulted in transient decreases in BSP removal rate in each case.
The subsequent eight studies were designed to measure the effect of more gradual but continuous changes in plasma concentration and were conducted as illustrated in Figure 6 (Dog Ot). A "priming" dose of BSP, approximately 12 mg per kg was administered, and this was followed by an infusion of approximately 0.15 mg per kg per minute. After a 30 to 40 minute equilibration period this rate of infusion usually produced a relatively constant or slowly changing arterial plasma level above 2.5 mg per 100 ml as in the illustration. After an initial phase of rapid "storage" uptake the BSP removal rate also becamne constant. Arterial and hepatic venous sampling was continued for an additional 30 minutes. The infusion rate was then doubled and measurements were continued at 10 minute intervals for another 50 minutes. At the high infusion rate the arterial concentration was observed to rise rapidly at first, but within approximately 20 minutes the rate of increase became less rapid and quite constant. Coincident with this the hepatic removal rate increased to a new constant value, considerably greater than the rate observed during the slower infusion. In the study illustrated the rate of change of arterial concentration with respect to time during the last 30 minutes of the initial BSP infusion was -0.0014 mg per 100 ml per minute and achieved a new constant value of + 0.0346 mg per 100 ml per minute during the more rapid infusion. The In D an identical increase in removal rate accompanied each of two successive increments in plasma level indicating additional "storage" uptake with each increment. where: I = infusion rate, mg per minute F = hepatic plasma flow, ml per minute A -V = splanchnic arteriovenous difference, mg per ml AP = rate of change of arterial concentration, mg per ml per minute ESPV = extrasplanchnic plasma volume, ml (assumed to be 0.8 X total plasma volume).
The magnitude of the extrahepatic removal rate, both in absolute terms and relative to total infusion rate, is shown in Table II . The average extrahepatic removal rate under the conditions of these studies was 9.2 per cent of the rate of infusion over a range of plasma BSP concentrations of approximatetly 3 to 16 mg per 100 ml. (Figures 3, 4, 5) leads to the conclusion that increments in plasma concentration result in an increase in hepatic BSP storage whereas decrements in concelntration are followed by a net (lepletion of stored BSP (since, in the latter case, sufficient BSP is certainly available in the liver to miaintain a maximal excretory rate during the perio(d of markedly reduced hepatic uptake from plasma). Apparently, then, the quantity of BSP which the liver can lhold in storage is determined b the concentration of the dye in the surrounding plasma. The capacity of the liver to store BSP (loes not appear, within the limited range of plasma colncentrations explored, to become 'saturated" in an absolute sense, since successive increments in plasma concentration result in additional "storalge 'uptake of BSP 1h the liver ( Figure 5D ). Moreover, in the last eight studies the fact that hepatic remiioval rate is much higher throughout a leriod of rising plasma concentration than during a relatively steady state indicates that a continuously increasing quantity of BSP can be stored in response to a constantly increasing plasma coIncentration. Under these circumstances the hepatic removTal rate includes a constant rate of movement This also applies to all experiments of the type illustrated by the first portion of Figure 3, (10) . However, it must be emphasized that the present studies were carried out under conditions of anesthesia, severe trauma and often reduced hepatic blood flows. While these conditions produced no obvious progressive impairment of the mechanisms under investigation, the precise numerical values may not apply to normal animals. C. Concentration of BSP in the liver. The relative storage capacity, as defined, has the dimensions of a volume, expressed in units of 100 ml. Thus, in a sense, an average "S" of 19.9 mg per mg per 100 ml per 10 kg means that the hepatic storage compartment of a 10 kg dog behaves as if it were an extension of the plasma compartment with a volume of 1,990 ml. Theoretically, therefore, one could define S as the hepatic "volume of distribution" of BSP, but compared with the known size of the liver the numerical values of S are absurdly large. Actually the dog's liver, exclusive of blood content, weighs only 235 g per 10 kg (an average figure for 14 dogs in which a prior injection of Cr5l-labeled red cells made it possible to estimate and subtract the blood content). In order to accommodate 19.9 mg of BSP for every mg per 100 ml change in plasma concentration, the liver must be capable, therefore, of storing BSP at more than eight times the concentration in the surrounding plasma. ( If the material were stored at a concentration just equal to that in plasma, a 235 g liver would have a storage capacity of only 2.35 mg per mg per 100 ml.) Since part of the weight of the liver is attributable to comparatively inert supporting tissue, and since there is no assurance that dye is uniformly distributed through the remaining parenchyma, it is probable that concentration of BSP in the actual hepatic storage sites may achieve an even higher ratio with respect to plasma concentration.
D. Storage and transport mechanisms. The present studies provide no information regarding the nature of the mechanisms by which BSP is concentrated in the liver and transported into the bile nor of the possible relationship between the two processes. The schema presented here is undoubtedly oversimplified. It has been shown by Krebs and Brauer (15) , for example, that BSP is partially converted by the liver into a number of chromatographically separable molecular species, some of which have definitely lower extinction coefficients than the parent compound at 580 m,u. Whatever the behavior of these products with respect to storage and excretion their formation represents, in effect, a "loss" of BSP color from the body and would hence be included in the excretory Tm as calculated herein. However, the resulting overestimation of Tm compared with the actual rate of biliary excretion is probably not very great, since over 70 per cent of administered BSE' is ultimately recoverable in the bile by simple colorimetry (3). Moreover, the major quantity of the derivatives is ultimately excreted in the bile, and to this extent properly belongs in the "Tm" calculation.
E. Simplification of technique. Even at the high plasma concentrations required for these studies the calculated removal of BSP by structures other than the liver was comparatively small. The figures shown in Table II (17); the results will be reported later in detail.
SUMMARY
The hepatic removal rate of sulfobromophthalein sodium (BSP) has been estimated in 14 dogs by means of measurements of hepatic blood flow (rotameter) and splanchnic arteriovenous concentration difference. During a constant BSP infusion hepatic BSP removal reaches a constant rate at an arterial concentration of 2 to 3 mg per 100 ml even when the latter continues to rise. Sudden increments in arterial concentration produce a marked transient increase in hepatic BSP removal rate and decrements produce a transient reduction. The hepatic removal rate is higher during continuously rising than during constant arterial BSP concentrations.
The data support the view that hepatic excretion of BSP depends upon a rate-limited transport mechanism and that the quantity of BSP stored in the liver parenchyma depends directly upon the concentration in the surrounding plasma. A method for calculating the excretory transport maximum (Tm) and the relative storage capacity (S) has been presented, based on ob-servations during two different constant rates of BSP infusion. The calculated values of storage capacity indicate that BSP in the hepatic storage compartment is maintained at a concentration more than eight times that in the plasma. In the range of plasma concentrations studied there was no evidence of "saturation" of the storage compartment. The extrahepatic removal rate of BSP is low enough so that Tm and S may be reasonably estimated from observations of peripheral plasma BSP concentrations during different rates of constant infusion, without resort to hepatic venous sampling or hepatic blood flow measurements.
